[1] LI W, YANG T, WANG CH.Current status and progress of prevention and treatment of chronic obstructive pulmonary disease in China[J]. China Research Hospital(中国研究型医院), 2020, 32(5): 1-5. [2] CHEN YH.2022 GOLD global strategy for diagnosis, treatment and prevention of chronic obstructive pulmonary disease[J]. Chin J Med Frontiers(中国医学前沿杂志), 2022, 25(11):1294-1304. [3] Chronic obstructive Pulmonary Disease Group, Chinese Society of Respiratory Medicine, Chinese Medical Doctor Association, Chronic obstructive pulmonary Disease Working Committee, Chinese Medical Doctor Association. Guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (2021 revision)[J]. Chin J Tuberculosis & Respiratory(中华结核和呼吸杂志), 2021, 44(3):170-205. [4] LIN YY, LIN GY, CHEN ZQ, et al.Observation on recent adverse reactions of inhalation therapy in 814 children with bronchial asthma[J]. Guangdong Medical Journal(广东医学), 2005, 26(5): 652. [5] LIPSON DA, BARNHART F, BREALEY N, et al.Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD[J]. N Engl J Med, 2018, 378(18): 1671-1680. [6] DONG T, WANG JM, ZHANG YM.A case report of compound ipratropium bromide solution and budesonide suspension induced adverse drug reaction[J]. Chin J Modern Nursing(中华现代护理杂志), 2017, 19(14): 1931-1932. [7] ZHENG FY, WU Y, RAO YF, et al.Role and case analysis of Noll assessment scale in evaluation of adverse drug reactions[J]. Chinese Journal of Pharmacy(中国药学杂志), 2012, 47(8) : 650-652. [8] LIN HW, DAI XY, LI CHJ.An overview of the literature on ambroxol induced anaphylaxis[J]. Chinese Journal of Drug Abuse Prevention and Control(中国药物滥用防治杂志), 2013, 17(4): 240-241. [9] LI M, YANG C, LI ZX, et al.Anaphylactic shock induced by doxofylline injection: a case report[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2019, 39(7): 767-768. [10] WANG WH, DENG SH, HUANG GH, et al.Determination of ambroxol hydrochloride tablets in human plasma by RP-HPLC method and its pharmacokinetics[J]. Journal of Pharmaceutical Analysis(药物分析杂志), 2001, 21(1): 23-25. [11] LEE H J, JOUNG SK, KIM YG, et al.Bioequivalence assessment of broxol tablet after a single oral dose administration to healthy male volunteers[J]. Pharmacol Res 2004, 49(1): 93-98. [12] XU YJ, ZHANG J, GUO DH, et al.Analysis of 1230 cases of drug-induced anaphylactic shock adverse reactions[J]. China Pharmaceutical Application and Surveillance(中国药物应用与监测), 2020,21(2): 99-103. [13] WOOD RA, CAMARGO CA, LIEBERMAN P, et al.Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States[J]. J Allergy Clin Immunol, 2014, 133(2): 461-467. [14] SHEFLER I,SALAMON P,MEKORI YA.MicroRNA involvement in allergic and non-allergic mast cell activation[J].Int J Mol Sci, 2019, 20(9): 2145. [15] BAHNA SL.Cow’s milk allergy versus cow milk intolerance[J]. Annals of Allergy Asthma and Immunology, 2012, 89(6): 56-60. [16] KLEBER RN, WEYRICH U,HINRICHS J.Screening for lactic acid bacteria with potential to reduce antigenic response of β-lactoglobulin in bovine skim and sweet whey[J]. Innovative Food Science and Emerging Technologies, 2006, 7(3): 233-238. [17] SHI J, ZHOU YD, LUO YK, et al.Detection and analysis of serum specific IgE binding between bovine milk protein and allergic children[J]. Journal of China Agricultural University(中国农业大学学报), 2017, 22(9): 40-44. [18] XIE HY, HAN SS, KE QI.Analysis of serum allergens in 1252 patients with allergic diseases[J]. Journal of Practical Preventive Medicine(实用预防医学), 2016, 23(4) : 462-464. [19] RANGEL AHD,SALES DC,URBANO SA,et al.Lactose intolerance and cow’s milk protein allergy[J]. Food Science and Technology,2016, 36(2): 179-187. [20] LIU HX,XUN HJ,REN YY,et al.Analysis of literature of 225 death cases with anaphylactic shock[J]. Chin Nursing Res, 2011, 25(2): 467-468. [21] LI X, MA Q, YIN J, et al.A clinical practice guideline for the emergency management of anaphylaxis (2020)[J] Front Pharmacol, 2022, 28(3): 13-22. |